Moreover, since high levels of anti-RV IgA and IgG in serum after infection resolution are good indicators of protection [11,12,69], it can be hypothesized that these interventions based on microbiota EVs can confer protection against RV infections later in life. The gene discussed is CD79A; the disease is infection.